Beatrice Tassone
DSM (Switzerland)(CH)University of Turin(IT)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Hippo pathway signaling and YAP/TAZ, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research
Most-Cited Works
- → PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling(2015)174 cited
- → Androgen receptor is a determinant of melanoma targeted drug resistance(2023)34 cited
- → Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis(2017)26 cited
- STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models.(2014)
- → Constitutive STAT3 activation in epidermal keratinocytes enhances cell clonogenicity and favours spontaneous immortalization by opposing differentiation and senescence checkpoints(2014)22 cited
- → CSL controls telomere maintenance and genome stability in human dermal fibroblasts(2019)22 cited
- → HSD17B7 gene in self‐renewal and oncogenicity of keratinocytes from Black versus White populations(2021)20 cited
- → Nuclear Akt2 Opposes Limbal Keratinocyte Stem Cell Self-Renewal by Repressing a FOXO-mTORC1 Signaling Pathway(2013)20 cited
- → The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome(2023)16 cited
- → Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation(2018)13 cited